BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 15 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 16 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 17 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 15 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 16 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 17 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago
ADVERTISEMENT
AlphaGraphs

JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2025 financial results

Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings results today. Reported sales increased 2.4% year-over-year to $21.9 billion. Operational sales growth was 4.2%. Net earnings rose to $11 billion, or $4.54 per share, from $3.25 billion, or $1.34 per share, last year. Adjusted EPS grew 2.2% to $2.77. Revenue and earnings beat […]

April 15, 2025 1 min read

Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings results today. Reported sales increased 2.4% year-over-year to $21.9 billion. Operational sales growth was 4.2%. Net earnings rose to $11 billion, or $4.54 per share, from $3.25 billion, or $1.34 per share, last year. Adjusted EPS grew 2.2% to $2.77. Revenue and earnings beat […]

· April 15, 2025

Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings results today.

Reported sales increased 2.4% year-over-year to $21.9 billion. Operational sales growth was 4.2%.

Net earnings rose to $11 billion, or $4.54 per share, from $3.25 billion, or $1.34 per share, last year. Adjusted EPS grew 2.2% to $2.77.

Revenue and earnings beat estimates.

The company raised its sales outlook for the full year of 2025 and now expects reported sales of $91.0-91.8 billion. Adjusted EPS guidance remains unchanged at $10.50-10.70.

ADVERTISEMENT

JNJ also declared a 4.8% increase in its quarterly dividend, from $1.24 per share to $1.30 per share. The stock was down in premarket hours on Tuesday.

Prior performance

ADVERTISEMENT